Patents by Inventor Nadya D. Belcheva

Nadya D. Belcheva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9517067
    Abstract: The present disclosure is directed to an implantable repository including a housing comprising at least one bioactive agent and at least one attachment member coupled to the housing, the at least one attachment member configured to couple the implantable repository to at least one of a medical device and a tissue surface.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: December 13, 2016
    Assignee: Covidien LP
    Inventors: Nadya D. Belcheva, Joshua Stopek
  • Patent number: 8969485
    Abstract: The present disclosure relates to coated biodegradable materials having a reduced amount of residual catalysts and methods thereof.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: March 3, 2015
    Assignee: Covidien LP
    Inventors: Nadya D. Belcheva, Norman Aminuddin
  • Publication number: 20150051540
    Abstract: The present disclosure is directed to an implantable repository including a housing comprising at least one bioactive agent and at least one attachment member coupled to the housing, the at least one attachment member configured to couple the implantable repository to at least one of a medical device and a tissue surface.
    Type: Application
    Filed: November 3, 2014
    Publication date: February 19, 2015
    Inventors: Nadya D. Belcheva, Joshua Stopek
  • Patent number: 8900616
    Abstract: The present disclosure is directed to an implantable repository including a housing comprising at least one bioactive agent and at least one attachment member coupled to the housing, the at least one attachment member configured to couple the implantable repository to at least one of a medical device and a tissue surface.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: December 2, 2014
    Assignee: Covidien LP
    Inventors: Nadya D. Belcheva, Joshua Stopek
  • Publication number: 20130296932
    Abstract: The present disclosure relates to coated biodegradable materials having a reduced amount of residual catalysts and methods thereof.
    Type: Application
    Filed: July 3, 2013
    Publication date: November 7, 2013
    Inventors: Nadya D. Belcheva, Norman Aminuddin
  • Patent number: 8501875
    Abstract: The present disclosure relates to coated biodegradable materials having a reduced amount of residual catalysts and methods thereof.
    Type: Grant
    Filed: August 12, 2011
    Date of Patent: August 6, 2013
    Assignee: Covidien LP
    Inventors: Nadya D. Belcheva, Norman Aminuddin
  • Publication number: 20120108760
    Abstract: The present disclosure relates to coated biodegradable materials having a reduced amount of residual catalysts and methods thereof.
    Type: Application
    Filed: August 12, 2011
    Publication date: May 3, 2012
    Inventors: Nadya D. Belcheva, Norman Aminuddin
  • Publication number: 20120100200
    Abstract: The present disclosure is directed to an implantable repository including a housing comprising at least one bioactive agent and at least one attachment member coupled to the housing, the at least one attachment member configured to couple the implantable repository to at least one of a medical device and a tissue surface.
    Type: Application
    Filed: October 22, 2010
    Publication date: April 26, 2012
    Inventors: Nadya D. Belcheva, Joshua Stopek
  • Patent number: 7030097
    Abstract: One aspect of the present invention relates to a nucleic acid delivery system including a polymeric structure formed of a biocompatible polymer and a mixture comprising one or more nucleic acid molecules and a first co-dispersant, the mixture being contained within the polymeric structure, wherein the first co-dispersant is present in an amount effective to control diffusion of the one or more nucleic acid from the polymeric structure. Compositions including the nucleic acid delivery system and a pharmaceutically-acceptable carrier are disclosed. Methods of making the nucleic acid delivery system and their use in delivering nucleic acid into a patient and modifying gene expression in a target cell are also disclosed.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: April 18, 2006
    Assignee: Cornell Research Foundation, Inc.
    Inventors: William Mark Saltzman, Dan Luo, Hong Shen, Kim Woodrow-Mumford, Nadya D. Belcheva